Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

NCT03880474 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2364

Enrollment

INDUSTRY

Sponsor class

Stopped The trial is being stopped for futility. Season 2 cancelled.

Conditions

Influenza

Interventions

BIOLOGICAL: MVA-NP+M1
DRUG: Saline

Sponsor

Barinthus Biotherapeutics

Collaborators

[object Object]